Medicare Enrolled
Dr. Alexey Ryskin, M.D.
Pain Medicine · Richland, WA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ryskin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ryskin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ryskin
Dr. Alexey Ryskin is a pain medicine specialist in Richland, WA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ryskin performed 24,680 Medicare services across 4,099 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ryskin received a total of $1,031 from 16 pharmaceutical and/or device companies across 55 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ryskin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 2% volume in WA
$1,031 industry payments
Medicare Practice Summary
Medicare Utilization ↗24,680
Medicare services
Top 2% in WA for pain medicine
4,099
Unique beneficiaries
$91
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,299 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
3,310 | $60 | $125 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
3,147 | $105 | $420 |
| Neuropsychological test evaluation, first hour A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process. |
3,088 | $109 | $390 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
3,072 | $32 | $105 |
| Psychological test evaluation, first hour A healthcare professional evaluates the results of psychological testing during an initial one-hour session. |
3,071 | $99 | $366 |
| Substance misuse assessment and brief intervention A structured assessment of alcohol or substance misuse combined with a brief intervention lasting 15 to 30 minutes. |
2,936 | $28 | $87 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
2,516 | $240 | $675 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
835 | $137 | $600 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
539 | $1 | $10 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
347 | $79 | $300 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
205 | $46 | $300 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
201 | $51 | $400 |
| Fine needle aspiration biopsy, first growth A procedure using a thin needle to remove cells or fluid from a growth for examination. |
173 | $67 | $368 |
| Remote therapeutic monitoring, additional 20 minutes This service covers the physician's time for managing remote therapeutic monitoring data beyond the initial monthly allotment. It applies for each additional 20-minute increment used within a calendar month. |
167 | $34 | $120 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
154 | $91 | $250 |
| New patient office visit, complex (60-74 min) | 137 | $173 | $679 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
106 | $46 | $160 |
| Remote therapeutic monitoring, first 20 minutes Physician management of remote therapeutic monitoring data for the first 20 minutes per calendar month. |
95 | $44 | $150 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
90 | $108 | $338 |
| Musculoskeletal remote monitoring device supply, 30 days A device supply that records and transmits data for remote monitoring of the musculoskeletal system over a 30-day period. |
82 | $47 | $120 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
58 | $46 | $98 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
55 | $148 | $350 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
55 | $177 | $611 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
53 | $88 | $306 |
| Additional sedation, per 15 minutes Administration of a drug to deepen sedation during a procedure. This code covers each additional 15-minute increment of sedation beyond the initial period. |
33 | $10 | $69 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
32 | $412 | $806 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
31 | $226 | $424 |
| Hip joint contrast injection for imaging A contrast dye is injected into the hip joint to enhance visibility during medical imaging procedures. |
21 | $197 | $500 |
| Suprascapular nerve injection An injection of anesthetic and/or steroid medication into the suprascapular nerve in the shoulder area. |
19 | $55 | $150 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 18 | $78 | $453 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
18 | $140 | $540 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
16 | $21 | $86 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2023 ↗$1,031
Total received (2018-2023)
Avg $172/year across 6 years
Bottom 31% in WA for pain medicine
16
Companies
55
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,031 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2023
$97
2022
$257
2021
$128
2020
$66
2019
$208
2018
$276
Payments by company (2023)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$38
Collegium Pharmaceutical, Inc.
$36
IBSA Pharma Inc.
$23
Top 3 companies account for 100.0% of 2023 payments
All-time payments by company (2018-2023) ›
Boston Scientific Corporation
$237
Abbott Laboratories
$196
Daiichi Sankyo Inc.
$163
Collegium Pharmaceutical, Inc.
$104
Nevro Corp.
$50
Allergan, Inc.
$49
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$43
BOSTON SCIENTIFIC CORPORATION
$42
IBSA Pharma Inc.
$23
Zimmer Biomet Holdings, Inc.
$23
GRT US Holding, Inc.
$22
Teva Pharmaceuticals USA, Inc.
$19
PFIZER INC.
$18
Amgen Inc.
$17
Purdue Pharma L.P.
$13
Egalet US Inc
$11
Top 3 companies account for 57.9% of all-time payments
Associated products mentioned in payments ›
AJOVY · Aimovig · Belbuca · CLINICAL TRIAL PRODUCT · Clinical Trial Product · LICART · LYRICA · Morphabond ER · Neuromodulation Dspsbls and Accs · Octrode SCS Leads · PROCLAIM · Proclaim Family of SCS IPGs · Proclaim IPG · Qutenza · RELISTOR · SCS IPGs · SPRIX · Senza Spinal Cord Stimulation System · Spectra WaveWriter · UBRELVY · VISCO-3 · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XTAMPZA · Xtampza ER
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pain medicines within 10 mi
3
Per 100K population
1.4
County median income
$87,316
Nearest hospital
KADLEC REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2023 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ryskin is a clinical cardiology specialist, with above-average Medicare volume (top 2% in WA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ryskin experienced with drug screening test?
Based on Medicare claims data, Dr. Ryskin performed 3,310 drug screening test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ryskin receive payments from pharmaceutical companies?
Yes. Dr. Ryskin received a total of $1,031 from 16 companies across 55 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ryskin's costs compare to other pain medicines in Richland?
Dr. Ryskin's average Medicare payment per service is $91. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ryskin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Richland
Browse pain medicines in Richland ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in WA
Pain medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in WA
Which WA pain medicines receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology